Biggest News Aggregation in the World
📰 Sun Xin News

Sun Xin News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Sun Xin. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration

BEIJING, June 23, 2022 /PRNewswire/ --Ocumension Therapeutics 1477.HKannounced that the New Drug Application (NDA) for the core product in its pipeline, OT-401 (Sterile non-bioerodible intravitreal implant, Product name: YUTIO), was officially approved by the National Pharmaceutical Administration (NMPA) for the treatment of chronic non-infectious uveitis involving the posterior segment of the eye (chronic NIU-PS). This is the first new drug in Ocumension's pipeline to be approved for market...
Chen Wei Liu Mimi Sun Xin Wenzhou Medical University Optometry Hospital Group Hainan Campus Drug Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science